Correction: Cost-effectiveness of oral versus injectable disease modifying therapies in relapsing multiple sclerosis: a systematic review analysis

Correction: Cost-effectiveness of oral versus injectable disease modifying therapies in relapsing multiple sclerosis: a systematic review analysis

Saved in:

Bibliographic Details
Main Authors:	Mehdi Rezaee, Ramin Ravangard, Seyyed Morteza Mojtabaeian, Abdosaleh Jafari
Format:	Article
Language:	English
Published:	BMC 2025-01-01
Series:	BMC Health Services Research
Online Access:	https://doi.org/10.1186/s12913-025-12280-0
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cost-effectiveness of oral versus injectable disease modifying therapies in relapsing multiple sclerosis: a systematic review analysis
by: Mehdi Rezaee, et al.
Published: (2024-10-01)

Matters arising: cost-utility and cost-effectiveness analysis of disease-modifying drugs of relapsing–remitting multiple sclerosis: a systematic review
by: Carlo Lazzaro, et al.
Published: (2025-01-01)

Comorbidity in in patients with relapsing-remitting multiple sclerosis
by: O.V. Somilo, et al.
Published: (2024-10-01)

Efficacy and safety of laquinimod versus placebo in relapsing-remitting multiple sclerosis: a systematic review and meta-analysis of randomized controlled trials
by: Malik Waleed Zeb Khan, et al.
Published: (2025-02-01)

Multiple sclerosis: overview of orally administrated disease-modifying drugs. Do genetics influence the success of treatment?
by: A. Ovčinikova, et al.
Published: (2019-03-01)

Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis Patients with Very Mild Clinical Disability
by: S. Migliore, et al.
Published: (2017-01-01)

Decrease of Mutual Information in Brain Electrical Activity of Patients with Relapsing-Remitting Multiple Sclerosis
by: Bruno Lenne, et al.
Published: (2013-01-01)

Familial Multiple Sclerosis with Repetitive Relapses of Manic Psychosis in Two Patients (Mother and Daughter)
by: Pedro J. Modrego, et al.
Published: (2000-01-01)

Bilateral Anterior and Intermediate Uveitis with Occlusive Vasculitis as Sole Manifestation of Relapse in Multiple Sclerosis
by: Angelica Pedraza-Concha, et al.
Published: (2019-01-01)

Response to treatment with Interferon beta-1a in patients with relapsing-remitting multiple sclerosis
by: Làzaro Aurelio Vàzquez Gòmez, et al.
Published: (2022-10-01)

Effectiveness of comprehensive neurorehabilitation treatment on the cognitive function of patients with relapsing-remitting multiple sclerosis
by: Làzaro Aurelio Vàzquez Gòmez, et al.
Published: (2022-05-01)

Serum neurofilament heavy chains as a biomarker of neuronal damage in multiple sclerosis relapse
by: P. Beliaziūnas, et al.
Published: (2021-03-01)

Survey on first-line therapeutic management of relapsing–remitting multiple sclerosis in clinical practice in Spain
by: M. Llaneza, et al.
Published: (2025-01-01)

Oral versus long-acting injectable antipsychotic in first episode schizophrenia: A 12 weeks interventional study
by: Ramandeep Kaur, et al.
Published: (2023-04-01)

Decreased Frequency of Circulating Myelin Oligodendrocyte Glycoprotein B Lymphocytes in Patients with Relapsing-Remitting Multiple Sclerosis
by: Annie Elong Ngono, et al.
Published: (2015-01-01)

Adherence to disease modifying therapies in patients with multiple sclerosis
by: D. Pileckė, et al.
Published: (2019-06-01)

The liminal space between hope and grief: The phenomenon of uncertainty as experienced by people living with relapsing-remitting multiple sclerosis.
by: Eva C van Reenen, et al.
Published: (2025-01-01)

Relapsing Remitting Multiple Sclerosis in X-Linked Charcot-Marie-Tooth Disease with Central Nervous System Involvement
by: Georgios Koutsis, et al.
Published: (2015-01-01)

A Pediatric Case of Relapsing-Remitting Multiple Sclerosis Onset following Varicella Zoster Ophthalmicus with Optic Neuritis
by: Naoko Shiba, et al.
Published: (2018-01-01)

Growth Arrest Specific Gene 6 Protein Concentration in Cerebrospinal Fluid Correlates with Relapse Severity in Multiple Sclerosis
by: P. P. Sainaghi, et al.
Published: (2013-01-01)

FutureMS cohort profile: a Scottish multicentre inception cohort study of relapsing-remitting multiple sclerosis
by: David Hunt, et al.
Published: (2022-06-01)

Repeat Intrathecal Triamcinolone Acetonide Application Reduces Acute Occurring Painful Dysesthesia in Patients with Relapsing Remitting Multiple Sclerosis
by: Kerstin Hellwig, et al.
Published: (2006-01-01)

Functional and Cognitive Impairment in Patients with Relapsing–Remitting Multiple Sclerosis: Cognitive Tests and Plasma Neurofilament Light Chain Levels
by: Elina Polunosika, et al.
Published: (2025-01-01)

Real-world satisfaction and experience with injection and autoinjector device for ofatumumab indicated for multiple sclerosis
by: Amy Perrin Ross, et al.
Published: (2025-01-01)

Efficacy Of Triamcinolone Injection In Management Of Oral Lichen Planus
by: Humera Iqbal, et al.
Published: (2024-03-01)

Blood biomarker dynamics in people with relapsing multiple sclerosis treated with cladribine tablets: results of the 2-year MAGNIFY-MS study
by: Heinz Wiendl, et al.
Published: (2025-02-01)

The Role of the New Anti-CD20 Monoclonal Antibodies in Active Relapsing – Remitting Multiple Sclerosis Treatment: Efficacy and Safety of ofatumumab
by: I. Jonušaitė, et al.
Published: (2024-03-01)

Comparative evaluation of oral hygiene status by using oral hygiene index, simplified oral hygiene index, and modified oral hygiene index: Revalidation of modified oral hygiene index
by: Subhash Garg, et al.
Published: (2024-07-01)

Lidocaine Versus Ketamine Pretreatment on Propofol Injection Pain
by: Amir Murad Khudadad Boujan, et al.
Published: (2019-12-01)

The Modified Gil-Vernet Antireflux Surgery: A Successful Technique for High-Grade Vesicoureteral Reflux Correction in Children—Long-Term Follow-Up
by: Mahmoudreza Moradi, et al.
Published: (2018-01-01)

Relapsing Polychondritis
by: Beata Sosada, et al.
Published: (2014-01-01)

A Review of the Effect of Injected Dextranomer/Hyaluronic Acid Copolymer Volume on Reflux Correction Following Endoscopic Injection
by: Sumit Dave, et al.
Published: (2008-01-01)

A Cost-effectiveness Analysis of Brentuximab Vedotin in Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma
by: Margaret Hux, et al.
Published: (2016-10-01)

Surgical Reimplantation for the Correction of Vesicoureteral Reflux following Failed Endoscopic Injection
by: Boris Chertin, et al.
Published: (2011-01-01)

Costs of Potential Medication Wastage Due to Switching Treatment Among People With Multiple Sclerosis
by: Darin T. Okuda, et al.
Published: (2024-10-01)

Adrenaline Injection Plus Argon Plasma Coagulation versus Adrenaline Injection Plus Hemoclips for Treating High-Risk Bleeding Peptic Ulcers: A Prospective, Randomized Trial
by: Seyed Alireza Taghavi, et al.
Published: (2009-01-01)

Recommendations for the treatment of multiple sclerosis with disease-modifying drugs during the COVID-19 pandemic
by: R. Kizlaitienė, et al.
Published: (2020-06-01)

TEC-ADHERE: Real-World Persistence and Adherence on Dimethyl Fumarate in Patients with Relapsing–Remitting Multiple Sclerosis in the French OroSEP Patient-Support Program
by: Pierre Labauge, et al.
Published: (2024-11-01)

An evaluation of surgical excision versus steroid injection for the management of ganglion cysts
by: Karpaka Vinayakam Gopalakrishnan, et al.
Published: (2025-01-01)

Cost-effectiveness of the Floodlight MS app in Austria. Unlocking the mystery of costs and outcomes of a digital health application for patients with multiple sclerosis
by: Evelyn Walter, et al.
Published: (2025-01-01)